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Abstract. Caused by the parasitic nematodes Toxocara canis and cati, toxocariasis in humans can result in covert
toxocariasis, ocular toxocariasis, visceral larval migrans, and neurotoxocariasis. A common infection, toxocariasis exposure varies widely within and between countries, with a previous estimate of Toxocara seroprevalence using data from
1988 to 1994 in the United States of approximately 13%. Age, poverty, sex, educational attainment, ethnicity, and region
have been associated with Toxocara seroprevalence. In this study, we sought to determine the seroprevalence of and
factors associated with Toxocara seropositivity in the United States using data from the National Health and Nutrition
Examination Survey from 2011 to 2014 to provide a more recent estimate of Toxocara seroprevalence in the United States.
We found an overall Toxocara seroprevalence of 5.1%. Increasing age, male sex, low educational attainment, low income,
and immigration status each was associated with Toxocara seropositivity. Mexican Americans had reduced odds of
exposure. These ﬁndings show that exposure to Toxocara continues in the United States and that several demographic
factors inﬂuence the risk of exposure.

INTRODUCTION

United States come from data collected between 1988 and
1994.16 In Denmark, one study found a Toxocara seroprevalence
of 2.4%,17 and Holland et al.18 found a seroprevalence of 31%
in school children in Ireland.18 In a particular area of Nigeria,
toxocariasis may have a seroprevalence of 86%.6
There are identiﬁed risk factors for Toxocara infection
in humans, although many of the ﬁndings have been inconsistent.1 Sociodemographic factors such as age, poverty,
ethnicity, sex, and geographical region appear to be associated with Toxocara seropositivity.15 For example, Toxocara
seroprevalence may exceed 20% in males in some US
counties, particularly in the South and Northeast.15 In addition, other factors associated with infection include pet
ownership,1,13 climate because Toxocara has optimal temperatures for breeding, and rurality with higher seroprevalence
in rural as compared with urban areas.13 Toxocara seroprevalence also differs across ethnic groups,10 suggesting that
cultural and genetic factors might affect seroprevalence.15
Furthermore, Won et al.14 found associations between Toxocara seropositivity and blood lead concentration, educational attainment, and socioeconomic status.
The US CDC periodically tests serum samples from the
NHANES for anti-Toxocara IgG antibodies and recently released data collected from 2011 to 2014 that contained antiToxocara IgG antibodies. Accordingly, our study objectives
were 2-fold: ﬁrst, to update seroprevalence estimates of
Toxocara in the United States because prior work used
NHANES data collected from 1988 to 1994 and second,
to investigate sociodemographic characteristics associated
with Toxocara seropositivity in the United States. In the previous report by Congdon and Lloyd,15 Toxocara seroprevalence was disaggregated by US counties and general
geographical regions. However, geographical or other location data in the NHANES data sets are restricted and require
funding to obtain. Therefore, we chose to report only ﬁndings
for the United States as a whole.

Toxocara canis and Toxocara cati are parasitic nematodes
responsible for human toxocariasis, a common1 and likely
underrecognized2,3 zoonotic helminth infection. Among the
nematodes found in the genus Toxocara, T. canis and T. cati
are the only Toxocara species known to cause human disease.
Toxocara infects humans via embryonated eggs in the environment, particularly in soil or in raw vegetables or other
foods,4,5 contaminated water,6 and possibly contact with dog
hair.7,8 Although routine veterinary care for household pets
may increase detection of the parasite and thereby decrease
risk for human exposure, infection is still prevalent throughout
the world.1 The major clinical conditions of human toxocariasis are covert toxocariasis, ocular toxocariasis, visceral larval migrans, and neurotoxocariasis.9,10 In the United States,
children11 and adults12 seropositive for toxocariasis had
worse cognitive function than did seronegative controls. In
fact, in mice, Toxocara infection has been associated with
biomarkers of Alzheimer’s disease.13
Despite the clinical signiﬁcance of human toxocariasis, the
epidemiology of toxocariasis remains insufﬁciently known.4,10
The prevalence of human toxocariasis appears to vary both
between9 and within countries.10 Regardless, toxocariasis appears to be one of the most common helminth infections in
humans worldwide.1,13 Previous estimates based on data from
the US Centers for Disease Control and Prevention’s (CDC) third
National Health and Nutrition Examination Survey (NHANES III)
suggest that approximately 14% of the population older than the
age of 6 years in the United States in 1988–1994 was seropositive for Toxocara species.14 Using the same dataset that Won
et al.14 used but with a different statistical approach, Congdon
and Lloyd15 found an overall US seroprevalence of 12.6% for
females and 14.6% for males. A systematic review of Toxocara
seroprevalence in North America suggested a prevalence
ranging from less than 1% in an indigenous group in Canada to
approximately 31% in a sample of children with asthma in
Mexico.16 However, the current estimates for this infection in the

MATERIALS AND METHODS
The National Center for Health Statistics (NCHS), a division
of the CDC, conducts the NHANES, a cross-sectional survey.
The NHANES uses a stratiﬁed, multistage cluster design to
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recruit a sample representative of the noninstitutionalized US
population and collects an extensive amount of sociodemographic, laboratory, examination, and other data from a large
number of individuals residing in various locations in the
United States. Before 1999, the CDC conducted the
NHANES irregularly, and the survey generally spanned multiple years, resulting in very large sample sizes. In 1999, the
CDC converted the NHANES to a continuous, 2-year cycle
format with approximately 10,000 participants in each cycle.
Although the NHANES collects much of the same data for
each NHANES cycle, some of the cycles, including the
NHANES III (1988–1994), contain data for variables that the
NHANES irregularly surveys, such as anti-Toxocara IgG antibodies. Until recently, data for Toxocara seropositivity was
available only for the NHANES III dataset. However, the availability of surplus sera from the 2011–2012 and 2013–2014
NHANES cycles enabled the CDC to assess again serum
samples for anti-Toxocara IgG antibodies, allowing a current
exploration of Toxocara seroprevalence and factors associated
with Toxocara seropositivity.
In the 2011–2012 and 2013–2014 cycles, the NHANES
assessed 13,509 participants aged 6 years and older for antiToxocara IgG antibodies and collected sociodemographic data
for all participants including age, sex, race-ethnicity, education,
poverty-to-income ratio (PIR), and immigrant status. Whereas
CDC technicians calculated Toxocara seroprevalence for the
entire study sample, we also computed seroprevalence for individual age groups (20–29, 30–39, 40–49, 50–59, 60–69,
70–79, and 80 years and over). Race-ethnicity groups included
non-Hispanic White, non-Hispanic Black, Mexican American,
and “Other” including other Hispanics, Asians, and individuals
reporting multiple races. Participants reported their greatest
level of educational achievement with potential options including less than ninth grade (less than high school), 9–11th
grade (high school) but no high-school diploma, high-school
graduate or GED recipient, some college or AA degree, and
college graduate or above. The CDC calculated a PIR for all
families and applied it to all individuals surveyed within a
household. The PIR is the ratio of the total family income to the
federal poverty level at the time of the survey. Although the PIR
is naturally a continuous variable, we recoded it into multiple
groups (0.00–0.99, 1.00–1.99, 2.00–2.99, 3.00–3.99, 4.00–4.99,
and 5.00+) for comparison purposes. The NHANES considered
participants born outside of the United States to be immigrants.
Laboratory testing. CDC laboratory technicians tested
serum samples for Toxocara-speciﬁc IgG antibodies using a
Luminex assay. A full description of the laboratory methods
used is on the NHANES website (https://wwwn.cdc.gov/
Nchs/Nhanes/2011-2012/SSTOCA_G.htm). The CDC considered results from the assay to be Toxocara seropositive if
the mean ﬂuorescence intensity was greater than 23.1 and
negative if the value was equal to or less than 23.1.
Statistical analyses. We used Stata version 14.219 for all
statistical analyses and used the svy preﬁx for all relevant commands to account for the NHANES sampling design. Before
analyses, we treated missing data using multiple imputation with
chained equations. The chained equations approach allows
for distribution-speciﬁc imputation equations (e.g., ordinary
least squares regression for continuous data and logistic regression for dichotomous data). We used twenty imputed
datasets. Two-hundred iterations separated each imputed
dataset. The graphical diagnostics indicated that the imputation

model converged well before that point.20 We computed means
or proportions, minimums, and maximums for each of the
sociodemographic variables we used in this study. We then used
logistic regression to estimate the relationship between Toxocara seropositivity and each of the sociodemographic variables
while controlling for all other variables. For example, we used
logistic regression to test for an association between Toxocara
seropositivity and sex while controlling for age, race-ethnicity,
education (we used head-of-household education for respondents younger than 20 years old), PIR, and immigrant status.
RESULTS
The study sample consisted primarily of young to middleaged adults [mean (standard deviation [SD]) = 38.6 (24.5)] and
included nearly equal numbers of males (48.8%) and females
(51.2%). The majority were non-Hispanic White (65.3%) and
had attained at least some post-high school education
(62.7%). The sample was relatively evenly distributed across
income levels, and approximately 15% were immigrants
( Table 1). The overall seroprevalence of Toxocara for respondents ages 6 years and over sampled in the 2011–2014
NHANES data cycles was 5.1% (95% conﬁdence interval [CI]:
4.3, 5.9). Seroprevalence by age group varied from 2.6% in the
group aged 6–9 years to 7.0% in the group aged 80 years and
older. In females, the overall seroprevalence was 3.9%, and in
males, the overall seroprevalence was 6.4%. For subjects with
no high-school diploma, the Toxocara seroprevalence was
10.1% but 3.2% for those with more than a high-school education. For a PIR of 0–0.999, the seroprevalence was 9.4%,
dropping to 2.2% for those with a PIR of ﬁve or higher. In
immigrants, the seroprevalence was 12.4%, compared with
3.7% for nonimmigrants ( Table 2). Table 3 reports odds ratios
TABLE 1
Weighted proportions of study variables
Age
6–9
10s
20s
30s
40s
50s
60s
70s
80+
Female
Race-ethnicity
Non-Hispanic white
Non-Hispanic black
Mexican American
Other
Education
No high school diploma
High school diploma
More than high school
Poverty-to-income
0–0.999
1–1.999
2–2.999
3–3.999
4–4.999
5+
Immigrant

Proportion

SE

4.4
13.6
15.0
14.4
15.3
15.5
11.7
6.4
3.7
51.2

0.22
0.37
0.94
0.55
0.53
0.51
0.48
0.31
0.25
0.38

65.3
10.9
9.8
14.0

2.6
1.4
1.4
0.99

16.6
20.7
62.7

1.2
0.83
1.6

18.7
21.7
15.1
12.9
9.3
22.4
15.6

1.2
0.93
0.55
0.77
0.57
1.5
1.2

SE = standard error. Unweighted N = 13,509. Source: Continuous NHANES, 2011–2014.
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TABLE 2
Weighted seroprevalence of Toxocara by study variables
95% CI
Unweighted N

Full sample
Age
6–9
10s
20s
30s
40s
50s
60s
70s
80+
Sex
Female
Male
Race-ethnicity
Non-Hispanic white
Non-Hispanic black
Mexican American
Other
Education
No high school diploma
High school diploma
More than high school
Poverty-to-income
0–0.999
1–1.999
2–2.999
3–3.999
4–4.999
5+
Nativity
Immigrant
Nonimmigrant

Percent positive

LL

TABLE 3
Sociodemographic predictors of Toxocara: odds ratios from logistic
regression

UL

13,509

5.1

4.3

5.9

1,149
2,712
1,636
1,686
1,645
1,592
1,586
914
589

2.6
3.9
4.6
4.8
5.4
6.5
4.8
6.5
7.0

1.4
2.9
3.2
3.7
4.2
4.6
3.2
4.9
4.3

3.7
4.9
6.0
5.9
6.7
8.3
6.3
8.1
9.6

6,859
6,650

3.9
6.4

3.1
5.5

4.6
7.3

4,972
3,114
2,010
3,413

3.8
6.7
6.1
9.1

3.0
5.5
4.2
6.9

4.7
8.0
8.0
11.3

3,156
2,951
7,402

10.1
6.7
3.2

8.4
5.3
2.7

11.8
8.0
3.8

3,712
3,522
1,859
1,473
977
1,966

9.4
6.1
4.4
3.9
3.8
2.2

7.6
4.8
3.2
2.6
2.0
1.4

11.2
7.3
5.6
5.2
5.6
3.0

3,248
10,261

12.4
3.7

10.1
3.0

14.7
4.4

CI = conﬁdence interval; LL = lower limit; UL = upper limit. Source: Continuous NHANES,
2011–2014.

corrected for all the other sociodemographic variables we
used from logistic regression for variables that represent risk
factors for Toxocara. Compared with subjects aged 6–9 years,
subjects aged 40 years or older were nearly twice as likely to
be seropositive for Toxocara. Females were about half as likely
to be seropositive as males (odds ratio [OR] = 0.54, 95% CI:
0.45, 0.65). Compared with subjects who self-identiﬁed as
non-Hispanic White, Mexican American subjects were also
about half as likely as being seropositive for Toxocara (OR =
0.52, 95% CI: 0.35, 0.79). Subjects who had attained education beyond high school were less likely to be seropositive
compared with subjects with less than a high-school education (OR = 0.49. 95% CI: 0.38, 0.64). Finally, immigrants were
more than three times as likely to be seropositive for Toxocara
as were nonimmigrants (OR = 3.3, 95% CI: 2.4, 4.7).
DISCUSSION
In this population-based study representative of 13,509
noninstitutionalized subjects weighted to represent the US
population, the overall weighted seroprevalence of Toxocara in
subjects aged 6 years and older was 5.1%. However, Toxocara
seroprevalence varied according to sociodemographic factors.
In general, males were nearly twice as likely to be seropositive
for Toxocara than were females, seropositivity tended to increase with age, and both education and socioeconomic status
were inversely associated with seroprevalence. These general

Age
6–9
10s
20s
30s
40s
50s
60s
70s
80+
Female
Race-ethnicity
Non-Hispanic white
Non-Hispanic black
Mexican American
Other
Education
No high school diploma
High school diploma
More than high school
Poverty-to-income
0–0.999
1–1.999
2–2.999
3–3.999
4–4.999
5+
Immigrant

OR

95% CI

1.00
1.5
1.6
1.6
2.0**
2.7***
2.0*
2.6**
2.9**
0.54***

–
0.94, 2.3
0.95, 2.8
0.97, 2.8
1.3, 3.2
1.6, 4.4
1.2, 3.6
1.5, 4.5
1.3, 6.2
0.45, 0.65

1.0
1.3
0.52**
1.0

–
0.99, 1.7
0.35, 0.78
0.72, 1.5

1.0
0.84
0.49***

–
0.64, 1.1
0.38, 0.64

1.0
0.68**
0.51**
0.50**
0.50*
0.31***
3.4***

–
0.51, 0.90
0.35, 0.76
0.33, 0.75
0.29, 0.87
0.17, 0.55
2.4, 4.8

OR = odds ratio; CI = conﬁdence interval. Unweighted N = 13,509. * P < 0.05, ** P < 0.01,
*** P < 0.001. Source: Continuous NHANES, 2011–2014.

trends are consistent with previous ﬁndings with infectious
diseases, including parasitic infections.12,18,21,22 In terms of
race-ethnicity, subjects self-reported as Mexican American had
reduced odds of infection (OR = 0.52), while all other raceethnicity categories had similar seroprevalence rates. Finally,
immigrants, regardless of race-ethnicity, were more than three
times as likely as to be seropositive than were nonimmigrants in
these US samples.
The weighted Toxocara seroprevalence of 5.1% that we
found in the combined 2011–2012 and 2013–2014 NHANES
datasets is lower than the 14% seroprevalence Won et al.14
reported and lower than the 12.6% seroprevalence in females
and 14.6% in males Congdon and Lloyd15 reported based on
the 1988–1994 NHANES dataset. This change in Toxocara
seroprevalence suggests a possible decrease in the seroprevalence of Toxocara in the United States since 1994.
However, differences in the assays used to detect Toxocara
and their cutoff points for seropositivity between the earlier
and later NHANES datasets preclude direct comparison of
Toxocara seroprevalence between the two NHANES datasets.
Based on these datasets, therefore, we cannot deﬁnitively
determine whether Toxocara seroprevalence in the United
States has changed since 1994. Nonetheless, the data we
used from the 2011–2012 and 2013–2014 datasets provide
the most up-to-date estimates of Toxocara seroprevalence in
the United States and indicate that Toxocara exposure remains present in the United States.
Despite the difﬁculty in making direct comparisons of Toxocara seropositivity between the earlier and later NHANES
datasets, we found that, similar to Congdon and Lloyd,15 male
sex, race-ethnicity, and socioeconomic status were associated
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with Toxocara seroprevalence. Although we found that males
were approximately twice as likely as females to be Toxocara
seropositive and that there were clear gradients with increasing
educational attainment and PIR and lower odds ratios of Toxocara seropositivity, Toxocara seroprevalence odds ratios did
not differ between non-Hispanic Blacks and non-Hispanic
Whites in adjusted models, although they both had higher odds
ratios than did Mexican Americans. These results suggest that
based on these models controlling for PIR and educational
attainment, Toxocara seroprevalence may differ less between
race-ethnicity groups in the US in 2011–2014 than it did in
1988–1994.
Consistent with prior work,23 we found that Toxocara
seroprevalence is higher in people with less educational attainment14 and lower income. Similar to Won et al.,14 we found
odd ratios for Toxocara seropositivity among people in their
20s and 30s of 1.5. However, in contrast to Won et al.,14 we
found that seroprevalence increased with age with the highest
odds ratios for Toxocara seropositivity occurring in people in
their 50s (odds ratio: 2.4) and 70s (odds ratio: 2.3) and in
those older than age 80 years (odds ratio: 2.6), suggesting that
exposure to Toxocara may increase with age in the United
States. In regard to Toxocara seropositivity and age, however,
not all studies have found an association between Toxocara
seroprevalence and increasing age. In La Plata, Argentina, for
instance, Toxocara seropositivity was higher in subjects under
age 15 years than in subjects older than 16 years.24 Won
et al.14 also found higher seroprevalence in subjects in their
20s and 30s compared with older subjects and speculated
that this may be due to increased soil exposure in children. In a
Jordanian sample aged 5–24 years, by contrast, Toxocara
seroprevalence was highest in females ages 5–9 years and in
males ages 15–19 years,25 pointing out that factors such as
sex might inﬂuence the association between age and seropositivity. The increased seroprevalence with age that we
found could reﬂect cohort effects or even changes in veterinary practices in detecting and treating animals with toxocariasis, as treatment guidelines for animals are now readily
available.26,27 Indeed, improved veterinary and household
care for pets could have led to higher detection rates in more
recent years thereby reducing the risk of infection in pets and,
subsequently, in humans. The increasing seropositivity with age
we found also might suggest that other sources of Toxocara
exposure besides soil may be relevant in the United States.
Several considerations affect the interpretation of these
ﬁndings. Enzyme-linked immunosorbent assay used to identify exposure to Toxocara can cross-react with antibodies to
other parasites, potentially inﬂating estimates of Toxocara
seroprevalence.28 In addition, we based our analyses on
cross-sectional data and so do not know the timing of the
initial exposure to Toxocara and whether subjects had additional exposures. Although we corrected for age, raceethnicity, education, PIR, and immigrant status, we might
well have missed other covariates related to Toxocara exposure, potentially resulting in residual confounding.
In conclusion, based on the most recently available
NHANES datasets containing information about the seroprevalence of Toxocara, we found a seroprevalence of 5.1% in the
United States, indicating that Toxocara exposure continues in
the United States. However, the risk of Toxocara exposure is
not evenly distributed through the US population but rather
relates to a variety of sociodemographic factors. Male sex,

increasing age, low educational attainment, and low PIR
were associated with Toxocara seropositivity. Subjects selfreported as Mexican American had reduced odds of infection,
whereas all other race-ethnicity categories had similar seroprevalences. Immigrants were more likely than nonimmigrants
to be Toxocara seropositive.
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